A treatment that is effective against hearing loss caused by the 'MPZL2 gene' mutation has been developed. A research team ...

Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.

Since 1921, when the first therapeutic peptide, insulin, was synthesized, many peptide-related accomplishments have reverberated throughout the industry, with more than 80 peptide drugs being approved ...

BRAF-positive non-small cell lung cancer (NSCLC) treatments can use the BRAF biomarker to provide effective, targeted treatment for this subset of lung cancer. BRAF-positive NSCLC is an uncommon or ...

Additionally, in 2025, the U.S. Food and Drug Administration (FDA) approved 11 drugs based on clinical trials in which MSK played a pivotal role. “MSK’s clinical research teams made great progress in ...

Dr Ambarish Ghosh, professor at IISc Bangalore explains how targeted nanorobots work against cancer, as well as the ...

Sequential BCL2 inhibitor therapy shows initial responses but lacks durability, especially in patients exposed to both BTKi ...

The MarketWatch News Department was not involved in the creation of this content. This press release is not intended for UK media. -- HERNEXEOS(R) (zongertinib tablets) approved based on an objective ...